169 related articles for article (PubMed ID: 1426886)
1. Hepatic cholesterol metabolism in estrogen-treated men.
Angelin B; Olivecrona H; Reihnér E; Rudling M; Ståhlberg D; Eriksson M; Ewerth S; Henriksson P; Einarsson K
Gastroenterology; 1992 Nov; 103(5):1657-63. PubMed ID: 1426886
[TBL] [Abstract][Full Text] [Related]
2. Influence of pravastatin, a specific inhibitor of HMG-CoA reductase, on hepatic metabolism of cholesterol.
Reihnér E; Rudling M; Ståhlberg D; Berglund L; Ewerth S; Björkhem I; Einarsson K; Angelin B
N Engl J Med; 1990 Jul; 323(4):224-8. PubMed ID: 2114543
[TBL] [Abstract][Full Text] [Related]
3. Cholesterol metabolism in human gallbladder mucosa: relationship to cholesterol gallstone disease and effects of chenodeoxycholic acid and ursodeoxycholic acid treatment.
Sahlin S; Ahlberg J; Reihnér E; Ståhlberg D; Einarsson K
Hepatology; 1992 Aug; 16(2):320-6. PubMed ID: 1639340
[TBL] [Abstract][Full Text] [Related]
4. In vitro studies of lipid metabolism in human liver.
Angelin B; Reihnér E; Rudling M; Ewerth S; Björkhem I; Einarsson K
Am Heart J; 1987 Feb; 113(2 Pt 2):482-7. PubMed ID: 3812206
[TBL] [Abstract][Full Text] [Related]
5. Regulation of hepatic cholesterol metabolism in humans: stimulatory effects of cholestyramine on HMG-CoA reductase activity and low density lipoprotein receptor expression in gallstone patients.
Reihnér E; Angelin B; Rudling M; Ewerth S; Björkhem I; Einarsson K
J Lipid Res; 1990 Dec; 31(12):2219-26. PubMed ID: 2090716
[TBL] [Abstract][Full Text] [Related]
6. HMG-CoA reductase, cholesterol 7alpha-hydroxylase, LDL receptor, SR-B1, and ACAT in diet-induced syndrome X.
Roberts CK; Liang K; Barnard RJ; Kim CH; Vaziri ND
Kidney Int; 2004 Oct; 66(4):1503-11. PubMed ID: 15458444
[TBL] [Abstract][Full Text] [Related]
7. HMG-CoA reductase, cholesterol 7alpha-hydroxylase, LCAT, ACAT, LDL receptor, and SRB-1 in hereditary analbuminemia.
Liang K; Vaziri ND
Kidney Int; 2003 Jul; 64(1):192-8. PubMed ID: 12787409
[TBL] [Abstract][Full Text] [Related]
8. Influence of bezafibrate on hepatic cholesterol metabolism in gallstone patients: reduced activity of cholesterol 7 alpha-hydroxylase.
Ståhlberg D; Reihnér E; Rudling M; Berglund L; Einarsson K; Angelin B
Hepatology; 1995 Apr; 21(4):1025-30. PubMed ID: 7705775
[TBL] [Abstract][Full Text] [Related]
9. HMG-CoA reductase inhibition reverses LCAT and LDL receptor deficiencies and improves HDL in rats with chronic renal failure.
Liang K; Kim CH; Vaziri ND
Am J Physiol Renal Physiol; 2005 Mar; 288(3):F539-44. PubMed ID: 15507547
[TBL] [Abstract][Full Text] [Related]
10. Molecular mechanisms of altered cholesterol metabolism in rats with spontaneous focal glomerulosclerosis.
Vaziri ND; Sato T; Liang K
Kidney Int; 2003 May; 63(5):1756-63. PubMed ID: 12675851
[TBL] [Abstract][Full Text] [Related]
11. Cholesterol metabolism: regulatory effects of the vagus in the normal and diabetic animal.
Scott LM; Tomkin GH
Diabetes Res; 1985 Nov; 2(6):313-7. PubMed ID: 4075700
[TBL] [Abstract][Full Text] [Related]
12. Increasing hepatic cholesterol 7alpha-hydroxylase reduces plasma cholesterol concentrations in normocholesterolemic and hypercholesterolemic rabbits.
Xu G; Salen G; Shefer S; Ness GC; Nguyen LB; Tint GS; Parker TS; Roberts J; Batta AK; Chen TS; Zhao Z; Kong X
Hepatology; 1996 Oct; 24(4):882-7. PubMed ID: 8855192
[TBL] [Abstract][Full Text] [Related]
13. Effects of HMG-CoA reductase inhibition on hepatic expression of key cholesterol-regulatory enzymes and receptors in nephrotic syndrome.
Vaziri ND; Liang K
Am J Nephrol; 2004; 24(6):606-13. PubMed ID: 15583480
[TBL] [Abstract][Full Text] [Related]
14. Hepatic cholesterol metabolism in human obesity.
Ståhlberg D; Rudling M; Angelin B; Björkhem I; Forsell P; Nilsell K; Einarsson K
Hepatology; 1997 Jun; 25(6):1447-50. PubMed ID: 9185766
[TBL] [Abstract][Full Text] [Related]
15. Effects of dietary soybean lecithin on plasma lipid transport and hepatic cholesterol metabolism in rats.
LeBlanc MJ; Brunet S; Bouchard G; Lamireau T; Yousef IM; Gavino V; Lévy E; Tuchweber B
J Nutr Biochem; 2003 Jan; 14(1):40-8. PubMed ID: 12559476
[TBL] [Abstract][Full Text] [Related]
16. Regulation of ovarian cholesterol metabolism: control of 3-hydroxy-3-methylglutaryl coenzyme A reductase and acyl coenzyme A:cholesterol acyltransferase.
Schuler LA; Toaff ME; Strauss JF
Endocrinology; 1981 Apr; 108(4):1476-86. PubMed ID: 7472277
[TBL] [Abstract][Full Text] [Related]
17. Effects of perturbations in hepatic free and esterified cholesterol pools on bile acid synthesis, cholesterol 7 alpha-hydroxylase, HMG-CoA reductase, acyl-CoA:cholesterol acyltransferase and cytosolic cholesteryl ester hydrolase.
Grogan WM; Bailey ML; Heuman DM; Vlahcevic ZR
Lipids; 1991 Nov; 26(11):907-14. PubMed ID: 1805095
[TBL] [Abstract][Full Text] [Related]
18. Ursodeoxycholic acid treatment in cholesterol gallstone disease: effects on hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase activity, biliary lipid composition, and plasma lipid levels.
Angelin B; Ewerth S; Einarsson K
J Lipid Res; 1983 Apr; 24(4):461-8. PubMed ID: 6854153
[TBL] [Abstract][Full Text] [Related]
19. Acyl-CoA: cholesterol acyltransferase and 3-hydroxy-3-methylglutaryl-CoA reductase in carp-liver microsomes: effect of cold acclimation on enzyme activities and on hepatic and plasma lipid composition.
Teichert T; Wodtke E
Biochim Biophys Acta; 1992 Dec; 1165(2):211-21. PubMed ID: 1450216
[TBL] [Abstract][Full Text] [Related]
20. Growth hormone and bile acid synthesis. Key role for the activity of hepatic microsomal cholesterol 7alpha-hydroxylase in the rat.
Rudling M; Parini P; Angelin B
J Clin Invest; 1997 May; 99(9):2239-45. PubMed ID: 9151797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
